0001140361-13-044973.txt : 20131204 0001140361-13-044973.hdr.sgml : 20131204 20131204191801 ACCESSION NUMBER: 0001140361-13-044973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131202 FILED AS OF DATE: 20131204 DATE AS OF CHANGE: 20131204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIMICK NEIL F CENTRAL INDEX KEY: 0001248380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 131258480 MAIL ADDRESS: STREET 1: 25913 RICH SPRINGS CIRCLE STREET 2: C/O WEBMD CORP CITY: LA GUNS HILLS STATE: CA ZIP: 92653 FORMER NAME: FORMER CONFORMED NAME: DIMICK NEIL F DATE OF NAME CHANGE: 20030626 4 1 doc1.xml FORM 4 X0306 4 2013-12-02 0 0000069499 MYLAN INC. MYL 0001248380 DIMICK NEIL F 1500 CORPORATE DRIVE CANONSBURG PA 15317 1 0 0 0 Common Stock 2013-12-02 4 M 0 14286 13.43 A 46422 D Common Stock 2013-12-02 4 S 0 14286 44.3042 D 32136 D Stock Option Right to Buy 13.43 2013-12-02 4 M 0 14286 0 D 2010-05-07 2019-05-07 Common Stock 14286 0 D Represents the weighted average price of the reporting person's disposition of 14,286 shares in transactions ranging from $44.22 to $44.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated December 12, 2012. /s/ Neil F. Dimick 2013-12-04